Tregs control the development of symptomatic West Nile virus infection in humans and mice

Journal of Clinical Investigation

Volumn 119, Issue 11, 2009, Pages 3266-3277

  Lanteri, Marion C ^a   O'Brien, Katie M ^b   Purtha, Whitney E ^b   Cameron, Mark J ^c   Lund, Jennifer M ^d   Owen, Rachel E ^a,e   Heitman, John W ^a   Custer, Brian ^a   Hirschkorn, Dale F ^a   Tobler, Leslie H ^a   Kiely, Nancy ^f   Prince, Harry E ^g   Ndhlovu, Lishomwa C ^e   Nixon, Douglas F ^e   Kamel, Hany T ^f   Kelvin, David J ^c,h   Busch, Michael P ^a,e   Rudensky, Alexander Y ⁱ   Diamond, Michael S ^b   Norris, Philip J ^a,e  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Blood Systems Incorporated   (United States)

^g Focus Diagnostics Inc   (United States)

^h SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TOGAVIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADULT; AGED; ANIMALS; BLOOD DONORS; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PHENOTYPE; RNA, VIRAL; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 70449377991     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39387     Document Type: Article

References (60)

1. Hayes, E.B., et al. 2005. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg. Infect. Dis. 11:1174-1179. (Pubitemid 41045322)
2. Centers for Disease Control. 2009. West Nile virus activity - Human disease cases reported. 2005-2009. http://www.cdc.gov/ncidod/dvbid/westnile/ surv&control.htm.
3. Busch, M.P., et al. 2006. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis. 12:395-402. (Pubitemid 43306263)
4. Samuel, M.A., and Diamond, M.S. 2006. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80:9349-9360.
5. Keller, B.C., et al. 2006. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80:9424-9434.
6. Wang, T., et al. 2003. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J. Immunol. 171:2524-2531. (Pubitemid 37025562)
7. Mehlhop, E., et al. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477. (Pubitemid 40756783)
8. Ben-Nathan, D., Huitinga, I., Lustig, S., van Rooijen, N., and Kobiler, D. 1996. West Nile virus neuro-invasion and encephalitis induced by macrophage depletion in mice. Arch Virol. 141:459-469. (Pubitemid 126706508)
9. Vargin, V.V., and Semenov, B.F. 1986. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol. 30:303-308.
10. Sanchez, M.D., et al. 2005. Characterization of neutralizing antibodies to West Nile virus. Virology. 336:70-82. (Pubitemid 40603672)
11. Ben-Nathan, D., et al. 2003. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J. Infect. Dis. 188:5-12. (Pubitemid 36829736)
12. Sitati, E.M., and Diamond, M.S. 2006. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80:12060-12069.
13. Wang, Y., Lobigs, M., Lee, E., and Mullbacher, A. 2003. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-13334. (Pubitemid 37494327)
14. Lobigs, M., Arthur, C.E., Mullbacher, A., and Blanden, R.V. 1994. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology. 202:195-201. (Pubitemid 24241991)
15. Lanteri, M.C., et al. 2008. Comprehensive analysis of west nile virus-specific T cell responses in humans. J. Infect. Dis. 197:1296-1306.
16. Shrestha, B., Samuel, M.A., and Diamond, M.S. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80:119-129.
17. Wang, Y., Lobigs, M., Lee, E., and Mullbacher, A. 2004. Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice. Immunol. Cell Biol. 82:170-173. (Pubitemid 38594648)
18. Pealer, L.N., et al. 2003. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349:1236-1245. (Pubitemid 37152033)
19. Arjona, A., et al. 2007. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117:3059-3066. (Pubitemid 47529635)
20. Wang, T., et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373. (Pubitemid 40022719)
21. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352. (Pubitemid 41716771)
22. Suvas, S., Kumaraguru, U., Pack, C.D., Lee, S., and Rouse, B.T. 2003. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198:889-901.
23. O'Garra, A., and Vieira, P. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10:801-805. (Pubitemid 39070850)
24. Kumar, V. 2004. Homeostatic control of immunity by TCR peptide-specific Tregs. J. Clin. Invest. 114:1222-1226. (Pubitemid 40385290)
25. O'Garra, A., Vieira, P.L., Vieira, P., and Goldfeld, A.E. 2004. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J. Clin. Invest. 114:1372-1378. (Pubitemid 40385564)
26. Shevach, E.M. 2001. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 193:F41-F46.
27. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
28. Takahashi, T., et al. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-310. (Pubitemid 30470313)
29. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135-142. (Pubitemid 34141443)
30. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
31. Hartigan-O'Connor, D.J., Poon, C., Sinclair, E., and McCune, J.M. 2007. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods. 319:41-52. (Pubitemid 46110995)
32. Liu, W., et al. 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203:1701-1711. (Pubitemid 44036276)
33. Custer, B., Kamel, H., Kiely, N.E., Murphy, E.L., and Busch, M.P. 2009. Associations between WNV infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 49:278-288.
34. Furtado, G.C., Curotto de Lafaille, M.A., Kutchukhidze, N., and Lafaille, J.J. 2002. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196:851-857.
35. McCandless, E.E., Zhang, B., Diamond, M.S., and Klein, R.S. 2008. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. U. S. A. 105:11270-11275.
36. Shrestha, B., and Diamond, M.S. 2004. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78:8312-8321. (Pubitemid 38944315)
37. Sharma, S., Dominguez, A.L., and Lustgarten, J. 2006. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J. Immunol. 177:8348-8355. (Pubitemid 44893796)
38. Brown, J.A., et al. 2007. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis. 7:479-488.
39. Diamond, M.S., Shrestha, B., Marri, A., Mahan, D., and Engle, M. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578-2586. (Pubitemid 36222782)
40. Fontenot, J.D., et al. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. (Pubitemid 40387475)
41. Kim, J.M., Rasmussen, J.P., and Rudensky, A.Y. 2007. Regulatory T cells prevent catastrophic auto-immunity throughout the lifespan of mice. Nat. Immunol. 8:191-197.
42. Prince, H.E., et al. 2005. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J. Clin. Microbiol. 43:4316-4320.
43. Annacker, O., et al. 2001. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008-3018.
44. Bettelli, E., et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238.
45. Peng, Y., Laouar, Y., Li, M.O., Green, E.A., and Flavell, R.A. 2004. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. U. S. A. 101:4572-4577. (Pubitemid 38437452)
46. Tesh, R.B., et al. 2005. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J. Infect. Dis. 192:287-295.
47. Luhn, K., et al. 2007. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J. Exp. Med. 204:979-985. (Pubitemid 46798142)
48. Jean, C.M., Honarmand, S., Louie, J.K., and Glaser, C.A. 2007. Risk factors forWest Nile virus neuro-invasive disease, California, 2005. Emerg. Infect. Dis. 13:1918-1920. (Pubitemid 350248498)
49. Lim, J.K., et al. 2008. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. J. Infect. Dis. 197:262-265.
50. Lund, J.M., Hsing, L., Pham, T.T., and Rudensky, A.Y. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science. 320:1220-1224. (Pubitemid 351929511)
51. Belkaid, Y., and Rouse, B.T. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6:353-360. (Pubitemid 41716772)
52. Chen, X., et al. 2007. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123:50-59. (Pubitemid 46420558)
53. Manigold, T., and Racanelli, V. 2007. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect. Dis. 7:804-813. (Pubitemid 350152043)
54. Cabrera, R., et al. 2004. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 40:1062-1071. (Pubitemid 39425561)
55. Sugimoto, K., et al. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 38:1437-1448. (Pubitemid 37466970)
56. Kinter, A.L., et al. 2004. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
57. Boyer, O., et al. 2004. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood. 103:3428-3430. (Pubitemid 38525674)
58. Smyk-Pearson, S., et al. 2008. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. J. Infect. Dis. 197:46-57.
59. Purtha, W.E., et al. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37:1845-1854.
60. Tobler, L.H., et al. 2008. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J. Infect. Dis. 198:979-983.